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Intr
Haematological malignancies are associated with treat-
ment releated morbidity and mortality. Intensive che-
motherapy and haematopoetic stem cell transplantation
has increased treatment releated complications. Trans-
ferring a severely ill patients to the intensive care unit
for life support is often a difficult decision.
Objectives
To detect risk factors effecting haematological malignancy
patients mortality after admission to the medical intensive
care unit.
Methods
This study was performed prospectively in the medical
intensive care unit of Erciyes Universty Hospital. History,
physical exam and laboratory findings on admisssion,and
therapeutic interventions during ICU stay were recorded.
The study end point was ICU mortality.
Results
32 (%60) of the 53 patients included into this study were
male. The average age of the patients was 49 ± 19 years.
The hematological diagnosis of the patients were as fol-
lows; 19 were AML, 12 were MM, 7 were Non-Hodgin
Lymphoma and 6were ALL. The most common reasons
for ICU admissions were respiratory failure (%57) and
septic shock (%17). The mean time delay starting from
deteriation to ICU was 6 hours (range 1-48). APACHE-2
score was 26 ± 8 and the early warning system score was
8 (range 1-14). APACHE-2 score and time delay for ICU
admission of nonsurvivors were higher (p= 0.009, 0.05
respectively). Serum total cortisol levels were lower in
survivors compared to nonsurvivors (p= 0.023). ICU
mortality rate was 60%.
Conclusions
The mortality rate of haematological malignancy patients
rate was high. The time delay for ICU admission and
APACHE-2 score were important risk factors for ICU
mortality. These patients should be admitted to the ICU
as soon as possible when vital signs are detoriated.
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